Recombinant Pig PMAP23 Protein，His

PMAP23, or Porcine/Mammalian Antimicrobial Peptide 23, is a notable antimicrobial peptide that has garnered significant attention in biomedical research due to its potential therapeutic applications. This peptide, derived from porcine sources, exhibits a broad spectrum of antimicrobial activities against various pathogens, including bacteria, fungi, and even certain viruses. The increasing prevalence of antibiotic resistance has prompted the urgent need for alternative antimicrobial strategies, positioning PMAP23 as a promising candidate. Research has indicated that PMAP23 functions through multiple mechanisms, such as disrupting microbial membranes and modulating immune responses, thereby enhancing its efficacy. Furthermore, its relatively low cytotoxicity in mammalian cells suggests a favorable safety profile, making it an attractive option for both veterinary and human medicine. Studies are actively exploring the optimization of PMAP23 through genetic engineering and synthetic biology approaches to improve its stability, efficacy, and delivery systems. As we advance our understanding of its structure-function relationships and mechanisms, PMAP23 could play a pivotal role in developing novel therapies to combat infections, particularly in an era where conventional antibiotics are becoming less effective. Overall, the research on PMAP23 not only highlights the importance of antimicrobial peptides in addressing global health challenges but also opens new avenues for innovation in antimicrobial drug development.